{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:19:22Z","timestamp":1788520762666,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Purpose<\/jats:title>\n<jats:p>Imaging studies of cobalt toxicity from cobalt-chromium alloy arthroprosthetics have focused on the local intra-articular and peri-articular presentation from failing joint replacements. Most studies investigating neurological findings have been small case series focused on the clinical findings of memory loss, diminished executive function, tremor, hearing and vision loss, depression, and emotional lability. This study utilizes software-based quantitative analysis of brain metabolism to assess the degree of hypometabolism and areas of susceptibility, determine if a pattern of involvement exists, and measure reversibility of findings after prosthetic revision to cobalt-free appliances.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Over 48\u00a0months, 247 consecutive patients presenting to an orthopedic clinic with an arthroprosthetic joint containing any cobalt-chromium part were screened with whole blood and urine cobalt levels. A clinically validated inventory of 10 symptoms was obtained. Symptomatic patients with a blood cobalt level above 0.4\u00a0mcg\/L or urine cobalt greater than 1\u00a0mcg\/L underwent F-18 FDG PET brain imaging. Analysis was performed with FDA-approved quantitative brain analysis software with the pons as the reference region. Control group was the normal brain atlas within the software.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Of the 247 consecutively screened patients, 123 had blood and urine cobalt levels above the threshold. The 69 scanned patients had statistically significant regional hypometabolism and higher symptoms inventory. Fifty-seven patients were retained in the study. Distribution of hypometabolism was in descending order: temporal, frontal, Broca\u2019s areas, anterior cingulate, parietal, posterior cingulate, visual, sensorimotor, thalamic, and lastly caudate. Metal-on-metal (MoM) and metal-on-plastic (MoP) joint replacements produced similar patterns of hypometabolism. Of 15 patients with necessary revision surgery, 8 demonstrated improved metabolism when later re-scanned.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>All scanned patients had regions of significant hypometabolism. Neurological toxicity from elevated systemic cobalt levels following arthroprosthetic joint replacement has a pattern of regional susceptibility similar to heavy metals and solvents, differing from classical dementias and may occur at blood and urine cobalt levels as low as 0.4\u00a0mcg\/L and 1\u00a0mcg\/L, respectively. Presently accepted thresholds for cobalt exposure and monitoring may need revision. Quantitative F-18 FDG PET brain imaging may aid in the decision process for treatment options and timing of possible medical versus surgical intervention.<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s00259-019-04648-2","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T10:03:46Z","timestamp":1576836226000},"page":"1961-1970","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["F-18 FDG PET brain imaging in symptomatic arthroprosthetic cobaltism"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2579-7875","authenticated-orcid":false,"given":"Robert L.","family":"Bridges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina S.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-7194","authenticated-orcid":false,"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2686-3213","authenticated-orcid":false,"given":"Stephen S.","family":"Tower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"key":"4648_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1302\/0301-620X.57B3.289","volume":"57","author":"DA Jones","year":"1975","unstructured":"Jones DA, Lucas HK, O\u2019Driscoll M, Price CH, Wibberley B. Cobalt toxicity after McKee hip arthroplasty. J Bone Joint Surg Br. 1975;57:289\u201396.","journal-title":"J Bone Joint Surg Br"},{"key":"4648_CR2","volume-title":"Trace elements in the environment volume 6-cobalt","author":"IC Smith","year":"1981","unstructured":"Smith IC, Carson BL. Trace elements in the environment volume 6-cobalt. 1981."},{"key":"4648_CR3","doi-asserted-by":"crossref","unstructured":"Catalani S, Rizzetti MC, Padovani A, Apostoli P. Neurotoxicity of cobalt. Hum Exp Toxicol. 2011.","DOI":"10.5402\/2011\/690620"},{"key":"4648_CR4","unstructured":"Gessner BD, Steck T, Woelber E, Tower SS. A systematic review of systemic cobaltism after wear or corrosion of chrome-cobalt hip implants. J Patient Saf. 2015."},{"issue":"3","key":"4648_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1302\/0301-620X.63B3.7263760","volume":"63-B","author":"T Rae","year":"1981","unstructured":"Rae T. The toxicity of metals used in orthopaedic prostheses. J Bone Joint Surg. 1981;63-B(3):435\u201340.","journal-title":"J Bone Joint Surg"},{"key":"4648_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/BOR.0000000000000161","volume":"27","author":"KD Allen","year":"2015","unstructured":"Allen KD, Golightly YM. Epidemiology of osteoarthritis: state of the evidence. Curr Opin Rheumatol. 2015;27:276.","journal-title":"Curr Opin Rheumatol"},{"key":"4648_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.joca.2016.11.005","volume":"25","author":"I Ackerman","year":"2017","unstructured":"Ackerman I, Bohensky M, De Steiger R, et al. Substantial rise in the lifetime risk of primary total knee replacement surgery for osteoarthritis from 2003 to 2013: an international, population-level analysis. Osteoarthr Cartil. 2017;25:455\u201361.","journal-title":"Osteoarthr Cartil"},{"key":"4648_CR8","first-page":"113","volume":"4","author":"SG Ghalme","year":"2016","unstructured":"Ghalme SG, Mankar A, Bhalerao Y. Biomaterials in hip joint replacement. Int J Mater Sci Eng. 2016;4:113\u201325.","journal-title":"Int J Mater Sci Eng"},{"key":"4648_CR9","doi-asserted-by":"publisher","first-page":"E106","DOI":"10.1148\/rg.344140010","volume":"34","author":"J Fritz","year":"2014","unstructured":"Fritz J, Lurie B, Miller TT, Potter HG. MR imaging of hip arthroplasty implants. Radiographics. 2014;34:E106\u201332.","journal-title":"Radiographics."},{"key":"4648_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1302\/0301-620X.98B7.37029","volume":"98-B","author":"RP Sidaginamale","year":"2016","unstructured":"Sidaginamale RP, Joyce TJ, Bowsher JG, et al. The clinical implications of metal debris release from the taper junctions and bearing surfaces of metal-on-metal hip arthroplasty: joint fluid and blood metal ion concentrations. Bone Joint J. 2016;98-B:925\u201333.","journal-title":"Bone Joint J"},{"key":"4648_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5301\/hipint.5000430","volume":"27","author":"JF Somers","year":"2017","unstructured":"Somers JF, Dedrye L, Goeminne S. Metal ion levels in ceramic-on-ceramic THR with cobalt-chrome modular necks: analysis of cobalt and chromium serum levels in 23 healthy hip patients. Hip Int. 2017;27:21\u20135.","journal-title":"Hip Int"},{"key":"4648_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12891-016-1329-8","volume":"17","author":"GS Matharu","year":"2016","unstructured":"Matharu GS, Pandit HG, Murray DW, Judge A. Adverse reactions to metal debris occur with all types of hip replacement not just metal-on-metal hips: a retrospective observational study of 3340 revisions for adverse reactions to metal debris from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. BMC Musculoskelet Disord. 2016;17:495.","journal-title":"BMC Musculoskelet Disord"},{"key":"4648_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/10667857.2017.1408929","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu Y, Chen B. In vivo corrosion of CoCrMo alloy and biological responses: a review. Mater Technol. 2018;33:127\u201334.","journal-title":"Mater Technol"},{"key":"4648_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12888-016-1174-1","volume":"17","author":"B Green","year":"2017","unstructured":"Green B, Griffiths E, Almond S. Neuropsychiatric symptoms following metal-on-metal implant failure with cobalt and chromium toxicity. BMC Psychiatry. 2017;17:33.","journal-title":"BMC Psychiatry"},{"key":"4648_CR15","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.2106\/JBJS.CC.15.00063","volume":"6","author":"E Woelber","year":"2016","unstructured":"Woelber E, Van Citters DW, Steck T, Glass GA, Tower S. Explant analysis from a patient exhibiting rapid acceleration of Parkinson disease symptoms and hypercobaltemia following metal-on-metal total hip arthroplasty. JBJS Case Connect. 2016;6:e45.","journal-title":"JBJS Case Connect"},{"key":"4648_CR16","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.3174\/ajnr.A3695","volume":"35","author":"K Ishii","year":"2014","unstructured":"Ishii K. PET approaches for diagnosis of dementia. Am J Neuroradiol. 2014;35:2030\u20138.","journal-title":"Am J Neuroradiol"},{"key":"4648_CR17","doi-asserted-by":"crossref","unstructured":"Jiang J, Sun Y, Zhou H, et al. Study of the influence of age in 18F-FDG PET images using a data-driven approach and its evaluation in Alzheimer\u2019s disease. Contrast Media Mol Imaging. 2018;2018.","DOI":"10.1155\/2018\/3786083"},{"key":"4648_CR18","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2967\/jnumed.107.040675","volume":"48","author":"L Mosconi","year":"2007","unstructured":"Mosconi L, Tsui WH, Pupi A, et al. 18F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer\u2019s disease. J Nucl Med. 2007;48:1129\u201334.","journal-title":"J Nucl Med"},{"key":"4648_CR19","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2967\/jnumed.111.090902","volume":"52","author":"K Herholz","year":"2011","unstructured":"Herholz K, Westwood S, Haense C, Dunn G. Evaluation of a calibrated 18F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment. J Nucl Med. 2011;52:1218\u201326.","journal-title":"J Nucl Med"},{"key":"4648_CR20","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2967\/jnumed.114.141416","volume":"55","author":"IM Nasrallah","year":"2014","unstructured":"Nasrallah IM, Wolk DA. Multimodality imaging of Alzheimer disease and other neurodegenerative dementias. J Nucl Med. 2014;55:2003\u201311.","journal-title":"J Nucl Med"},{"key":"4648_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1053\/j.semnuclmed.2008.02.006","volume":"38","author":"DH Silverman","year":"2008","unstructured":"Silverman DH, Mosconi L, Ercoli L, Chen W, Small GW. Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. Semin Nucl Med. 2008;38:251\u201361.","journal-title":"Semin Nucl Med"},{"key":"4648_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1006\/enrs.1993.1039","volume":"60","author":"TJ Callender","year":"1993","unstructured":"Callender TJ, Morrow L, Subramanian K, Duhon D, Ristovv M. Three-dimensional brain metabolic imaging in patients with toxic encephalopathy. Environ Res. 1993;60:295\u2013319.","journal-title":"Environ Res"},{"key":"4648_CR23","first-page":"1450","volume":"45","author":"E Imabayaashi","year":"2004","unstructured":"Imabayaashi E, Matsuda H, Asada T, et al. Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer\u2019s disease from controls using brain perfusion SPECT. J Nucl Med. 2004;45:1450\u20137.","journal-title":"J Nucl Med"},{"key":"4648_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5491\/SHAW.2012.3.4.243","volume":"3","author":"Y Kim","year":"2012","unstructured":"Kim Y, Kin JW. Toxic encephalopathy. Saf Health Work. 2012;3:243\u201356.","journal-title":"Saf Health Work"},{"issue":"9","key":"4648_CR25","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3174\/ajnr.A3922","volume":"35","author":"MJ Clark","year":"2014","unstructured":"Clark MJ, Prentice JR, Hoggard N, et al. Brain structure and function in patients after metal-on-metal hip resurfacing. AJNR Am J Neuroradiol. 2014;35(9):1753\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"4648_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40572-015-0056-x","volume":"2","author":"SL O\u2019Neal","year":"2015","unstructured":"O\u2019Neal SL, Zheng W. Manganese toxicity upon overexposure: a decade in review. Curr Environ Health Rep. 2015;2(3):315\u201328.","journal-title":"Curr Environ Health Rep"},{"key":"4648_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1289\/ehp.877559","volume":"75","author":"TW Clarkson","year":"1987","unstructured":"Clarkson TW. Metal toxicity in the central nervous system. Environ Health Perspect. 1987;75:59\u201364.","journal-title":"Environ Health Perspect"},{"key":"4648_CR28","unstructured":"Langley A, Dameron C. Modern metal implant toxicity and anaesthesia. Research Gate, 2015."},{"key":"4648_CR29","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s11999-012-2398-0","volume":"470","author":"F Fritzsche","year":"2012","unstructured":"Fritzsche F, Borisch C, Schaefer C. Case report high chromium and cobalt levels in a pregnant patient with bilateral metal-on-metal hip arthroplasties. Clin Orthop Relat Res. 2012;470:2325\u201331.","journal-title":"Clin Orthop Relat Res"},{"issue":"12","key":"4648_CR30","first-page":"20","volume":"194","author":"X Mao","year":"2011","unstructured":"Mao X, Andrew Wong A, Crawford R. Cobalt toxicity \u2014 an emerging clinical problem in patients with metal-on-metal hip prostheses. MJA. 2011;194(12):20.","journal-title":"MJA"},{"key":"4648_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ymgmr.2018.09.005","volume":"17","author":"K Stepien","year":"2018","unstructured":"Stepien K, Abidin Z, Lee G, et al. Metallosis mimicking a metabolic disorder; a case report. Mol Genet Metab Rep. 2018;17:38\u201314.","journal-title":"Mol Genet Metab Rep"},{"issue":"4","key":"4648_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.artd.2015.09.002","volume":"1","author":"A Harris","year":"2015","unstructured":"Harris A, Johnson J, Mansuripur P, Limbird R. Cobalt toxicity after revision to a metal-on-polyethylene total hip arthroplasty for fracture of ceramic acetabular component. Arthroplasty Today. 2015;1(4):88\u201391.","journal-title":"Arthroplasty Today"},{"issue":"5","key":"4648_CR33","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1080\/17453670610013079","volume":"77","author":"W Steens","year":"2006","unstructured":"Steens W, Von Foerster G, Katzer A. Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip\u2014a case report. Acta Orthopaedica. 2006;77(5):830\u20132.","journal-title":"Acta Orthopaedica"},{"key":"4648_CR34","doi-asserted-by":"publisher","first-page":"8335","DOI":"10.1039\/c2cc33016d","volume":"48","author":"A Goode","year":"2012","unstructured":"Goode A, Perkins J, Ann Sandison A, et al. Chemical speciation of nanoparticles surrounding metal-on-metal hips. Chem Commun. 2012;48:8335\u20137.","journal-title":"Chem Commun"},{"key":"4648_CR35","first-page":"7","volume":"8682737","author":"A Giampret","year":"2016","unstructured":"Giampret A, Lonati D, Ragghianti B. N-acetyl-cysteine as effective and safe chelating agent in metal-on-metal hip-implanted patients: two cases. Case Rep Orthop. 2016;8682737:7.","journal-title":"Case Rep Orthop"},{"issue":"6","key":"4648_CR36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.etp.2012.09.006","volume":"65","author":"P Apostoli","year":"2013","unstructured":"Apostoli P, Catalani S, Zaghini A, et al. High doses of cobalt induce optic and auditory neuropathy. Exp Toxicol Pathol. 2013;65(6):719\u201327.","journal-title":"Exp Toxicol Pathol"},{"key":"4648_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11999-012-2526-x","volume":"471","author":"C Van Der Straeten","year":"2013","unstructured":"Van Der Straeten C, Grammatopoulos G, Gill H, et al. The interpretation of metal ion levels in unilateral and bilateral hip resurfacing. Clin Orthop Relat Res. 2013;471:377\u201385.","journal-title":"Clin Orthop Relat Res"},{"key":"4648_CR38","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.2106\/JBJS.M.00160","volume":"96","author":"YM Kwon","year":"2014","unstructured":"Kwon YM, Lombardi AV, Jacobs JJ, et al. Risk stratification algorithm for management of patients with metal-on-metal hip arthroplasty: consensus statement of the American Association of Hip and Knee Surgeons, the American Academy of Orthopaedic Surgeons, and the Hip Society. J Bone Joint Surg Am. 2014;96:e4.","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"4648_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/15563650.2013.857024","volume":"52","author":"D Paustenbach","year":"2014","unstructured":"Paustenbach D, Galbraith D, Finley B. Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol. 2014;52(2):98\u2013112.","journal-title":"Clin Toxicol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04648-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04648-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04648-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T00:12:28Z","timestamp":1608336748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04648-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["4648"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04648-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"assertion":[{"value":"28 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The University of Alaska-Anchorage IRB determined that the use of redacted patient data did not meet the definition of human subject research under the purview of the IRB according to federal regulations. Letter of determination dated May 2, 2019, is available for review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}